A live archive of receipt-bound excerpts from company earnings calls. No generated thesis, no recommendation — just the recorded language, its source coordinates, and a direct path into the ticker dossier or live Terminal.来自公司财报电话会的可追溯摘录档案。没有生成式投资结论，也没有推荐——只有原始表述、来源坐标，以及进入个股档案或实时终端的直接入口。
Start free in Terminal免费开始使用终端649 verified call records份已核验电话会记录 · 7788 exact facts条精确事实 · 2026-10-26 → 2026-11-01
Browse the full archive page by page. Search on this page by ticker, period, category, or speaker; every card preview is a verbatim call excerpt.分页浏览完整档案。在本页按代码、期间、分类或发言人搜索；每张卡片预览均为电话会原文摘录。
Showing records 5281–5376 of 6702.显示第 5281–5376 条，共 6702 条。
“Gross margin for the quarter was 37.7% compared to 41.4% in the fourth quarter, and reflects the ongoing impact of supply chain dynamics, but especially revenue and product mix.”
“Calendar 2026 marks our third full year of operation in the market with our business on track for substantial growth.”
“Turning back to the full year, we continue to estimate a foreign exchange benefit of approximately 100 basis points on sales growth and are holding operating margin in the range of 21%-21.5%, an increase of 50 basis points-100 basis points over prior year, despite significant headwinds from tariffs annualizing and inflationary impacts.”
“The Q3 GAAP diluted earnings per share was $0.72 compared to guidance of at least $0.52, and non-GAAP diluted EPS was $0.84 versus guidance of at least $0.60 due to higher gross margins.”
“During the first quarter of 2026, we generated revenue and grant income of $3.1 million, driven primarily by the progress towards the site acceptance testing milestone under our Line Installation Agreement with SK On and performance on our assistance agreement with the U.S.”
“The expected sources of growth are consistent with the drivers that we saw in Q1, with the one key difference being that our Q2 revenue guidance assumes approximately a half point of FX tailwinds versus the more than 2 points of FX tailwinds that we saw in Q1.”
“While Andaz will certainly provide a lift to our results all year, the impact will become less pronounced as we get further into the year and begin to lap more of last year's operations, with the revenue growth benefit estimated at approximately 500 basis points in the second quarter and 150-200 basis points in each of the third and fourth quarters.”
“Our GAAP gross profit percentage was 29.2% and adjusted gross profit percentage was 29.6%, slightly below our expectations and impacted by product mix, higher freight costs, tariffs, and temporary labor inefficiencies as we start new lines and train new employees to meet the very strong demand we see ahead.”
“As a reminder, our full year 2026 guidance does not factor in any potential impact of M&A.”
“ACV growth was primarily driven by our top 20 pharma customers as these customers broaden their platform access, onboard new products, and integrate our platform more deeply into their R&D organizations.”
“We expect this to increase on a quarterly basis throughout 2026 due to investments in CMC supporting RM-718, increased spending on clinical trials, increased spending on clinical supply of bivamelagon ahead of our planned phase III trial in hypothalamic obesity, and the ongoing build-out of our team in Japan and preclinical work associated with our CHI program.”
“As it pertains to our updated pro forma guidance for 2026, which now excludes the immunodiagnostics business in China, we are now looking for organic growth of 3%-4%, adjusted operating margins of 28.4%, and adjusted earnings per share of $5.20-$5.30, which includes a 20% reduction related to the planned divestiture, offset by $0.05 of benefit from improved operational execution throughout the year.”
“Shifting to gross margin, we expect gross margin in the second quarter of 2026 of between 54.1% and 54.6%, which implies an increase of 25 basis points year-over-year at the midpoint of the range.”
“We expect 2026's free cash flow in the range of $125 million-$135 million for the full year, flat with prior year performance at the midpoint, and a free cash flow margin of approximately 15.5%.”
“Intelligent Devices margin of 20.9% increased by 320 basis points year-over-year and was ahead of our expectations due to positive price cost inclusive of productivity, higher sales volume, and favorable mix, partially offset by higher compensation.”
“As a result, we are maintaining our 2026 revenue guidance for total revenues of $275 million-$290 million, including net product sales of $255 million-$265 million.”
“Including these announcements, our firm full year 2026 and 2027 contract coverage is currently 86% and 73% respectively, providing a strong base for future cash flow and a line of sight to continued debt and interest expense reduction.”
“We are reiterating our expectation for 9%-13% organic growth while updating our reported revenue guidance to reflect the sale of our non-core and low-margin Polymem business.”
“We continue to expect to recognize GAAP revenue of $50 million-$65 million for the full year of 2026.”
“Secondly, in terms of profitability projections, given that PRVs are selling for, you know, substantially over $100 million at this point, any color on what you're modeling in terms of PRV monetization and whether we can expect that full year 2027 profitability to be sustainable?”
“For AMT-260 in refractory mesial temporal lobe epilepsy, enrollment in our phase I/II-A study is on track, and we expect to report data from the first cohort in the second quarter.”
“With this strong performance, EPS for the first quarter of 2026 was $1.95 per diluted share, and our free cash flow was $93.6 million, representing a 53% margin compared to 67% in the prior year.”
“We remain focused on improving cash flow generation still expect positive cash flow for the full-year, now expected to be in the range of $100 million-$120 million, with positive cash flow driven by higher revenue in the second half of the year.”
“Pulling all this together, for the second quarter, we expect low single-digit revenue growth on a currency-neutral basis, a low single-digit or approximately 3% decline in transaction margin dollars, transaction margin dollars excluding interest to decline low single digits or approximately 2%, mid-single-digit growth in non-transaction OpEx, and non-GAAP EPS to decline by high single digits or approximately 9%.”
“Restaurant-level adjusted EBITDA decreased $1.8 million-$34.8 million, with margins declining approximately 170 basis points to 19.1% in the quarter versus 20.8% in the prior year.”
“All these changes did not impact our guidance for the year, which remains in reiterating digital revenue growth of mid to high single digits, delivering total company adjusted EBITDA in the $310-$340 range.”
“We remain on pace to complete approximately 30 securitizations in 2026, which we expect will build a substantial foundation of investments with returns on equity in the low to mid-teens to support future earnings.”
“Net cash used in operating activities of $1 million was in line with the prior year, primarily due to improved earnings, which offset higher working capital driven by the increased demand.”
“Correspondent channel margins were 28 basis points, up from 25 basis points in the prior quarter due to a shift in mix towards higher margin government loans given the increased levels of competition from the GSE cash window, combined with a meaningful increase in average revenue per loan.”
“Albert, just going back to last December's guidance call, you highlighted $17 billion of annual revenue impacted by LOEs by 2030, and now with the tafamidis patent settlement extending that to mid-2031, your comments that you are aiming to achieve high single-digit, five-year revenue growth, starting in 2029.”
“The first quarter distribution margin increased by $0.07 per share compared to the year-ago period and largely reflects incremental gas margin from the third quarter 2025 GSMP II extension roll-in, an increase in the number of customers in the quarter, and higher gas demand outside of the decoupling mechanism.”
“That backlog provides us with good visibility into the revenue ramp ahead, and we are reiterating our full-year 2026 revenue guidance of $24 million-$27 million, which implies approximately 357%-415% growth compared to 2025.”
“Finally, we are maintaining our free cash flow margin guidance of 19%, which implies year-over-year free cash flow margin expansion of approximately 280 basis points.”
“These include all statements about our competitive position, product advantages and growth opportunities, anticipated industry trends, our business and strategic priorities, our OpEx targets, the impact of our recent acquisition, the development and expansion of our products, our products' capabilities and performance, and our revenue guidance for the second quarter of 2026 and long-term financial targets.”
“On slide 22, we are affirming our annual diluted earnings per share guidance range of $5.22-$5.62, which is expected to produce a return on equity of approximately 12%.”
“We expect to see year-on-year growth in off-lease volumes throughout the remainder of 2026 and beyond.”
“This surge in demand across both front-end and advanced packaging resulted in first quarter revenue above our original guidance range and is expected to continue with the heightened outlook for the second quarter revenue, which at the midpoint represents a 20% increase year-over-year.”
“Turning to segment performance, our Offshore Manufactured Products segment generated revenues of $91 million and Segment Adjusted EBITDA of $19 million in the first quarter, resulting in an Segment Adjusted EBITDA margin of 20%.”
“We continue to meet our growth targets while maintaining a strong focus on customer affordability, which was particularly important during a volatile winter.”
“Moving down the P&L, pro forma non-GAAP adjusted growth margin was 70.7%, a 40 basis point improvement over prior year, reflecting the impact of freight and logistics productivity improvements, partially offset by unfavorable geography mix.”
“During the quarter, 12 units were sold or placed under contract, compared to a full year underwriting assumption of six unit sales.”
“The optimal dose, which is the medium dose, demonstrated a 31% reduction in lesion growth relative to control at 12 months, with a P value of less than 0.05.”
“In fact, revenue from our high power business grew up to 25% year-over-year, with all four of our targeted high power end markets increasing sequentially in Q1.”
“The company reported that 2.5 million members globally, 103% year-over-year bookings growth in 2025, a $1.1 billion exit run rate, and positive operating cash flow in 2025.”
“The new project acquisitions that make that up as designed will ensure long-term, high margin, and recurring revenue streams, as reflected in the strong contract backlog growth that, as you see, is over $1.3 billion, made up primarily of our own and operate projects now, projects that are pre-funded through our existing Asset Vault platform.”
“We are targeting mid-single-digit organic growth in Sealing Technologies, while at AST, we are targeting at least high single-digit organic growth, with both segments capable of generating 30% adjusted segment EBITDA margins ±250 basis points through 2030.”
“We expect Affordable Care, a dental business specializing in higher margin tooth replacement and implant services, to come off non-accrual in the coming quarters as the lending group effectuates a change in control.”
“We expect to increase installed capacity by an additional 50% through the end of fiscal 2027, supported by a pipeline of safe harbored investment options in markets with supportive policy and strong demand growth.”
“As a result, we've adjusted our full year same store SHOP NOI growth to a range of 1%-3%.”
“With INGREZZA guidance reaffirmed at $2.7 billion-$2.8 billion, CRENESSITY now annualizing at over $600 million per year, and the pending addition of VYKAT XR to our commercial portfolio, we are well-positioned to deliver record net product sales in 2026.”
“Beyond Q1 revenue, we reported solid gross margin of 69% in line with our full year range.”
“Q2 total revenue guidance assumes a $10 million negative impact from Tinder's user experience tests and a $20 million negative impact from lower Azar direct revenue.”
“We've said that we target about 10%-20% of Bitcoin reserves annually in digital credit volume.”
“These results reflect ongoing focus on our four priority areas with highlights that include solid execution across our broad portfolio of production and development programs, backlog growth of 18% year-over-year and a sequential increase of 12-month backlog of 10.3%, a streamlined operating structure enabling increased positive operating leverage and significant margin expansion, and continued progress on Free Cash Flow drivers with Net Working Capital down 4.1% year-over-year.”
“For the Cash App impact, yeah, I mentioned that, you know, for the full year, we had stated 1.5-2 percentage points of gross profit growth impact.”
“A strong domestic and international demand drove increased Gulf Coast margins, resulting in an incremental $596 million of adjusted EBITDA.”
“We think the combination of revenue growth driving gross margin, the creative cog, the hosting cog, and the other cogs, having discipline around them will put us, you know, squarely in a position to stay in the long-term target of 75%-80%.”
“Like I said, it's part of the reason why, you know, our guidance is the back half of 2026 is, you know, one of these, you know, bad multifamily loans roll into the next quarter can be a, you know, $0.03 or $0.04 swing in DE or the timing of that resolution.”
“When I'm looking at pricing above 4%, are there any potential headwinds or impacts that we should be aware of or maybe that you have internally that could reduce the trajectory of this growth going forward?”
“While it takes time for the impact of these measures to fully flow through our financial results, we expect our SG&A to net sales ratio, excluding deal and restructuring costs, to improve in the second half of 2026 as these benefits phase in.”
“From a margin standpoint, we expect to drive significant improvement in gross margins approaching 30%, while operating expenses as a percentage of sales decrease to less than 20% from the 25% in 2025.”
“These two new offerings are another example of how we're innovating to help enterprise customers deliver on their AI ambitions, while simultaneously giving Lumen an opportunity to capture some of the over $2 billion in annual revenue currently served by carrier-neutral facility cross connects.”
“In April, we closed on sale-leaseback transactions that generated approximately $200 million of sale-leaseback proceeds and expect to complete approximately $400 million for the full year, supporting our ongoing focus on generating annual positive free cash flow.”
“Concrete revenues decreased by 1.9% year-over-year, despite a 14% increase in volumes.”
“I mean, does it mean you're targeting the mid to high single-digit organic growth for fiscal year 2027, and margins, I mean, coming down 50 basis points or 100 basis points?”
“We are increasing our annual guidance for gross margin to 72.3% and operating to $79.8 million, representing 24% growth over adjusted 2025 operating income.”
“Turning to our non-GAAP results, third quarter gross margin was 47.9%, which was up 540 basis points sequentially, up 1,270 basis points year-over-year, due to better manufacturing utilization across the majority of our product lines, increased pricing on select products, and favorable product mix.”
“Sales and marketing costs increased $7.7 million or 27.2%, primarily due to increased royalties associated with the final royalty rate step up under our National Geographic agreement and investments in demand generation efforts.”
“Maintaining our adjusted EBITDA margin guidance at mid-thirteens, raising our non-GAAP diluted EPS guidance of by $0.05, yielding $12.10-$12.50, and increasing our operating cash flow guidance by $50 million to approximately $1.8 billion.”
“Pull-through weighted rate lock volume came in within the guidance we issued last quarter of $7.75 billion to $8.75 billion, and contributed to adjusted total revenue of $299 million, which compared to $316 million in the fourth quarter of 2025.”
“Despite the subdued industry backdrop, driven by our self-help initiatives and growth platforms, we continue to expect full-year revenue of $4.2 billion-$4.3 billion and an operating profit margin in the range of 7.5%-8%.”
“Among the highlights, first, we expanded our partnership with Uber to provide a minimum of 35,000 Robotaxis, up from 20,000 previously announced, and increased their investment to $500 million, up from $300 million, improving our visibility into long-term demand and revenue in a new and growing market.”
“We're also raising our full year 2026 non-GAAP operating income guidance to a range of $222 million-$228 million, a non-GAAP operating margin of approximately 14.5%-15%.”
“The company exited the quarter with around $500 million of liquidity post these transactions, with additional liquidity to be created from the EG sale and from free cash flow going forward.”
“Starting with aggregates, our 26% volume growth, coupled with price increases and cost controls, drove strong margin improvement.”
“To give you a sense of the embedded profitability, as we've done the last couple of quarters, our insurance operating earnings would have been slightly north of $300 million in Q1 if we included the impact of marks on investments where a significant portion of the return relates to appreciation rather than cash yield.”
“Taken together, this results in revenue phasing of approximately 47% in the first half and 53% in the second half, reflecting a relatively stable Mission Tech run rate and second half growth in Sustainable Tech as customer activity normalizes and recent wins ramp, particularly in regions impacted by the Middle East disruptions.”
“Service levels and customer demand remain consistent, and Q1 puts us on a solid trajectory toward our full-year revenue guidance of $105 million-$115 million.”
“Putting this all together, we expect our revenue to grow at a three year organic compound annual rate of 5%-7%, and we are targeting an adjusted EBITDA margin of 20% in 2028, supported by our margin enhancement initiatives and volume growth.”
“Our 2026 full year guidance does include assumptions that generics will build volumes in the second half of the year, as well as the potential for the entry of new wake-promoting agents entering the market in the second half of the year in the NT1 narcolepsy segment.”
“In the first quarter, we reduced our share count by about 4%, buying back $535 million of stock, and we expect to generate significant free cash flow and have fewer shares outstanding over the course of the next several years.”
“One quarter of bookings, $2.5 billion of bookings that are gonna be to revenue over the next four to seven years, is not going to affect our margins, one bit.”
“And adjusted EBITDA totaled $49 million, with an adjusted EBITDA margin of 21%, well above the high end of our guidance range.”
“Turning to our guidance, for the fourth quarter of fiscal 2026, we expect SaaS revenue to be between $113.1 million-$114.1 million.”
“Following up on your 2027 commentary, appreciate that you're planning to provide more details next quarter, but as you think about initial enrollment growth, what are your initial thoughts on your aggregate patient risk scores and new member acuity mix?”
“Turning to our Q1 net sales bridge, the 1% decrease was driven by $32 million in lower volume and $22 million in lower price mix, partially offset by $33 million of favorable foreign exchange translational impacts.”
“In addition, we are working on several secured and unsecured financing transactions that have not yet closed, totaling nearly $130 million, including a $56.5 million financing at a rate of 8.75% that we expect to be funded today.”
“Our first quarter revenues were $392 million, representing an increase of 2.4% on a reported basis and an organic increase of 1.3%, reflecting continued strong demand for our portfolio, improved supply, increased visibility, and strong performance in Tissue Reconstruction.”
“As Mark mentioned, today we affirm our annual RVR margin and adjusted EPS guidance, which includes RVR in a range of $1.78 billion-$1.86 billion, adjusted EBITDA in a range of 14.5%-15% of RVR, and adjusted non-GAAP EPS in a range of $8.35-$9.15.”
“As we have consistently communicated throughout 2025, we have increased leverage to support our continued growth and return objectives, allowing us to continue to focus on what we believe are high-quality originations versus chasing higher yielding assets with more risk.”
“For the second quarter, we expect our revenue growth rate will approximate 9.5% and adjusted EBITDA margin will approximate 23%.”
“Our growth outlook, combined with the progress made on value creation initiatives and a strong start to the year, reinforces my confidence and my commitment that we will deliver on our 2026 financial guidance.”
“We continue to target a dividend payout ratio for 2026 of 50% of earnings per ordinary share, excluding material notable items and related impacts.”
“In terms of cash flow, net cash used in operating activities for the quarter was $4.2 million compared to a cash usage of $1.6 million in the first quarter of 2025.”
“From a margin standpoint, we expect to drive significant improvement in growth margins approaching 30%, while operating expenses as a percentage of sales decrease to less than 20% from the 25% in 2025.”
“Our operating margin was 25%, generating $46 million in operating income, exceeding our guidance range of $30 million-$32 million for the quarter.”
Try a ticker, period, category, or a call speaker.请尝试代码、期间、分类或电话会发言人。
This is a transcript-only, historically incomplete publication. Releases, filings, slides, consensus and price reaction are visibly marked as not joined; lower-evidence packets remain held instead of being inferred.这是仅基于电话会文本且历史覆盖尚不完整的发布。新闻稿、披露文件、演示材料、一致预期和股价反应均明确标注为未接入；证据不足的数据包会被暂缓，而非由推断补齐。